菲利華(300395.SZ):就受讓並增資取得中益科技60%股權 已完成工商變更
格隆匯7月12日丨菲利華(300395.SZ)公佈,此前披露,擬通過受讓上海璽斌商務諮詢合夥企業(有限合夥)、江蘇斯凱氟複合材料有限公司、浙江豪納新材料有限公司、自然人胡德兵所持有的中益(泰興)環保科技有限公司(“中益科技”)51.88%的股權。為支持中益科技後續業務發展資金需求,公司擬對中益科技增加註冊資本855.036萬元,認購價為人民幣2131.50萬元。增資完成後,中益科技註冊資本將增加至5067.036萬元,公司將持有中益科技60%的股權。
近日,中益科技的工商登記手續已經完成變更,並領取了新的營業執照,公司持其60%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.